DaVita Inc. logo
DaVita Inc. (DVA)
Compare

DaVita Inc. (DVA) Earnings Per Share (EPS): 9.94

popular:market cap|pe ratio|revenue|price history|total return

Is DaVita Inc.’s earnings per share (EPS) high or low?

DaVita Inc.'s earnings per share (EPS) of 9.94 is 19% above its 5-year average of 8.35, near the high end of its 5-year range (5.88–11.02).

As of Saturday, June 20, 2026. 4.15% below its 12-month average of 10.37.

P/E Ratio|EPS CAGR|Net Income|Earnings Yield|All Metrics

DVA Earnings Per Share (EPS) Chart

DVA Earnings Per Share (EPS)
9.72-11.80% 1Y
Zoom

DVA Average Earnings Per Share (EPS) Chart

DVA Current vs Average Earnings Per Share (EPS) Chart

DVA Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

9.94

EARNINGS PER SHARE (EPS) AVG TTM

10.37

EARNINGS PER SHARE (EPS) AVG 3Y

8.56

EARNINGS PER SHARE (EPS) AVG 5Y

8.35

EARNINGS PER SHARE (EPS) AVG 10Y

6.29

EARNINGS PER SHARE (EPS) AVG 15Y

5.18

EARNINGS PER SHARE (EPS) AVG 20Y

4.34

CURRENT VS TTM AVG

-4.15%

CURRENT VS 3Y AVG

+16.12%

CURRENT VS 5Y AVG

+19.09%

CURRENT VS 10Y AVG

+58.12%

CURRENT VS 15Y AVG

+91.87%

CURRENT VS 20Y AVG

+129.28%

DVA Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
DaVita Inc. (DVA)$13.34B9.9410.378.568.35
Medpace Holdings, Inc. (MEDP)vs ›$13.14B15.9214.3511.379.10
Solventum Corporation (SOLV)vs ›$13.06B8.175.856.827.06
Align Technology, Inc. (ALGN)vs ›$13.04B5.965.645.439.01
The Cooper Companies, Inc. (COO)vs ›$12.85B1.181.921.8211.98
Revvity, Inc. (RVTY)vs ›$11.16B2.102.252.013.78
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B-7.29-6.79-1.56-0.26
Baxter International Inc. (BAX)vs ›$10.27B-2.10-1.51-0.650.36
Hologic, Inc. (HOLX)vs ›$16.97B2.402.923.224.07
Zimmer Biomet Holdings, Inc. (ZBH)vs ›$17.02B3.854.003.512.55

EPS Comparison

Trailing EPS (TTM)

$9.94

Forward EPS (Est.)

$14.85

P/E Ratio

20.9

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

DaVita Inc. Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

DaVita Inc. Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for DaVita Inc. (DVA)?
The earnings per share (EPS) for DVA stock is 9.94.
Is DaVita Inc.'s earnings per share (EPS) high or low?
DaVita Inc.'s earnings per share (EPS) of 9.94 is 19% above its 5-year average of 8.35, near the high end of its 5-year range (5.88–11.02).
What is the TTM average earnings per share (EPS) for DaVita Inc. (DVA)?
The TTM average earnings per share (EPS) for DVA stock is 10.37.
What is the 3Y average earnings per share (EPS) for DaVita Inc. (DVA)?
The 3Y average earnings per share (EPS) for DVA stock is 8.56.
What is the 5Y average earnings per share (EPS) for DaVita Inc. (DVA)?
The 5Y average earnings per share (EPS) for DVA stock is 8.35.
What is the 10Y average earnings per share (EPS) for DaVita Inc. (DVA)?
The 10Y average earnings per share (EPS) for DVA stock is 6.29.
What is the 15Y average earnings per share (EPS) for DaVita Inc. (DVA)?
The 15Y average earnings per share (EPS) for DVA stock is 5.18.
What is the 20Y average earnings per share (EPS) for DaVita Inc. (DVA)?
The 20Y average earnings per share (EPS) for DVA stock is 4.34.

DaVita Inc. Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2025-12-319.72
2024-12-3111.02
2023-12-317.62
2022-12-315.88
2021-12-319.30
2020-12-316.54
2019-12-315.29
2018-12-314.63
2017-12-313.52
2016-12-314.36
2015-12-311.27
2014-12-313.41
2013-12-313.02
2012-12-312.79
2011-12-312.52
2010-12-312.00
2009-12-312.04
2008-12-311.78
2007-12-311.80
2006-12-311.40
2005-12-311.13
2004-12-311.13
2003-12-310.93
2002-12-310.73
2001-12-310.55
2000-12-310.06
1999-12-31-0.60
1998-12-31-0.02
1997-12-310.24
1996-12-310.14

Related Metrics

P/E RatioEPS CAGRNet IncomeEarnings YieldAll Metrics

About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Denver, CO
76,000 employees
www.davita.com
Healthcare / Medical - Care Facilities
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Javier J. Rodriguez
View full financials